Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients

Publisher： Karger

E-ISSN： 1423-0194|95|4|344-350

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.95, Iss.4, 2012-02, pp. : 344-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chromogranin A in Diagnosing and Monitoring Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Large Series from a Single Institution

By  

Neuroendocrinology, Vol. 100, Iss. 2-3, 2014-11 ,pp. : 240-249

Karger

Access to resources Recommend Favorite

Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-03 ,pp. : 19-25

Karger

Access to resources Recommend Favorite

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

By  

Neuroendocrinology, Vol. 96, Iss. 4, 2012-10 ,pp. : 261-271

Karger

Access to resources Recommend Favorite

Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 89, Iss. 3, 2008-10 ,pp. : 296-301

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

By  

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 186-194

Karger

Access to resources Recommend Favorite